Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Applying to Abramson Cancer Center of the University of Pennsylvania · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.